Insider Purchases: Inside the Buy

Tag: AI Stocks

Digital illustration of a DNA strand fusing with glowing AI circuitry inside a futuristic lab, symbolizing Absci’s generative AI drug discovery technology.

Absci: When AI Meets Antibodies — and Insiders Can’t Resist Buying More!

AI is designing drugs, and Absci is leading the charge — with insider confidence, top-tier partners, and a cash runway through 2028. Still pre-revenue but packed with promise, this biotech might just be the next NVIDIA of antibodies.

Read entire article

Tags: Absci, ABSI, ABSI Stock, AI, AI in Biotech, AI Stocks, Almirall, AMD, Ark Invest, Biotech, Biotech Humor, Biotech Innovation, Biotech Investing, Biotech Investments, Biotech Partnerships, Biotech Stocks, Buy ABSI Stock, CFO Bought Shares, CFO Insider Buying, CFOBuyIn, Chief Innovation Officer Buying Shares, Director Insider Buying, drug discovery, FMR, Funanc1al, Funanc1al Edge, insider purchases, institutional ownership, investing humor, Oracle, Redmile Group, speculative stocks
Colorful illustration of a silicon chip glowing like a jewel, surrounded by servers and AI robots cheering, symbolizing Marvell Technology’s insider confidence and AI growth.

Insiders Think Marvell Is a Wonder at Current Price; Should You Emulate the CEO, CFO, and Presidents and Buy MRVL?

Insiders, buybacks, and AI growth — oh my! Marvell Technology’s execs just bought millions in stock. With a $5B buyback, should you marvel too?

Read entire article

Tags: AI Stocks, CEO Buys, CEO Conviction, CEO insider buying, CEO Stock Purchase, CEOBuyIn, CEOConfidence, CFO Bought Shares, CFO Insider Buying, CFOBuyIn, COO Insider Buying, Funanc1al, Funanc1al Edge, Funanc1al Investing, Insider Buys, Is MRVL Stock a Buy, Marvell Technology, MRVL, President Buy Stocks, Semiconductor Stocks, Stock Market News, Tech Growth Investment, Tech Investing, Undervalued Growth